IL6 and cancer: IL-6 has been implicated in tumourigenesis by promoting cell proliferation, angiogenesis and resistance to apoptosis in several cancers [13–15], including CC, and is now considered a critical biomarker and therapeutic target in various diseases, particularly in inflammation-related pathologies and cancer [11, 13–15].